Main > ONCOLOGY (**) > Lymphoma>HL>Classical>R/R *** > TREAT.: > CN. I. SintiliMAb Inj.>

---

CN. I. SintiliMAb Inj.>'s subsections
(*) CN Approval Date: 2018. 12.27.
>2 Lines of Systemic CT
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2019. 12.24.
PR Web-Site
TradeMark

CN. I. SintiliMAb Inj.>'s products
This section has no products